Overview

A Study of the Safety and Efficacy of Infliximab in Patients With Psoriasis

Status:
Completed
Trial end date:
2004-10-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine if infliximab (anti-TNF) is effective in the treatment of plaque psoriasis.
Phase:
Phase 3
Details
Lead Sponsor:
Centocor, Inc.
Treatments:
Infliximab